In vitro Activity of Ceftazidime, Cefepime and Imipenem on 1,005 Pseudomonas aeruginosa Clinical Isolates either Susceptible or Resistant to Beta-Lactams

Publisher： Karger

E-ISSN： 1421-9794|46|4|229-234

ISSN： 0009-3157

Source： Chemotherapy, Vol.46, Iss.4, 2000-06, pp. : 229-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Activity of Levofloxacin and Ciprofloxacin in Combination with Cefepime, Ceftazidime, Imipenem, Piperacillin-Tazobactam and Amikacin against Different Pseudomonas aeruginosa Phenotypes and Acinetobacter spp.

By  

Chemotherapy, Vol. 50, Iss. 4, 2004-10 ,pp. : 202-210

Karger

Access to resources Recommend Favorite

In vitro Activity of Azithromycin in Combination with Amikacin, Ceftazidime, Ciprofloxacin or Imipenem against Clinical Isolates of Acinetobacter baumannii

By  

Chemotherapy, Vol. 49, Iss. 1-2, 2003-05 ,pp. : 24-26

Karger

Access to resources Recommend Favorite

In vitro Activity of Combination Therapy with Cefepime, Piperacillin-Tazobactam, or Meropenem with Ciprofloxacin against Multidrug-Resistant Pseudomonas aeruginosa Strains

By  

Chemotherapy, Vol. 49, Iss. 6, 2003-12 ,pp. : 294-297

Karger

Access to resources Recommend Favorite

Characterization of Fluoroquinolone and Carbapenem Susceptibilities in Clinical Isolates of Levofloxacin-Resistant Pseudomonas aeruginosa

By  

Chemotherapy, Vol. 51, Iss. 2-3, 2005-06 ,pp. : 70-75

Karger

Access to resources Recommend Favorite

Serum Bactericidal Activity of Piperacillin/Tazobactam against Staphylococcus aureus, Piperacillin-Susceptible and Piperacillin-Resistant Escherichia coli and Pseudomonas aeruginosa

By  

Chemotherapy, Vol. 50, Iss. 1, 2004-04 ,pp. : 27-30

Karger

Access to resources Recommend Favorite